Ovarian Cancer
New ovarian cancer study results reported from University of Miami
Published in Women's Health Weekly, March 25th, 2010
According to recent research published in the journal Gynecologic Oncology, "Current treatment options for epithelial ovarian cancer are limited and therapeutic development for recurrent and drug-resistant ovarian cancer is an urgent agenda. We investigated the potential use of genetically engineered Vesicular Stomatitis Virus (VSV) to treat ovarian cancer patients who fail to respond to available therapies."
"Specifically, we examined the toxicity to hosts and specificity of targeting ovarian tumors using a Wv ovarian tumor model. We first tested recombinant VSV for oncolytic activity in a panel Of human ovarian epithelial cancer, immortalized, and primary...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- American Cancer Society
Improvements needed in genomic test result discussions - Columbia University Medical Center
Acupuncture may relieve joint pain caused by some breast cancer treatments - Elsevier Health Sciences
Is prenatal screening for rare diseases like spinal muscular atrophy too costly? - EQ Biosciences, Inc.
Supplement blocks the initiation of breast cell mutations by estrogens - Apoptosis
New apoptosis study results from C. Garciagarcia et al described - Apoptosis
Scientists at Kaohsiung Medical University release new data on apoptosis - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
